Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 6/2003

01-06-2003

Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing α-fetoprotein

Authors: Shigeo Kamei, Koji Kono, Hideki Amemiya, Akihiro Takahashi, Hidemitsu Sugai, Fumiko Ichihara, Hideki Fujii, Yoshirou Matsumoto

Published in: Journal of Gastroenterology | Issue 6/2003

Login to get access
Metadata
Title
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing α-fetoprotein
Authors
Shigeo Kamei
Koji Kono
Hideki Amemiya
Akihiro Takahashi
Hidemitsu Sugai
Fumiko Ichihara
Hideki Fujii
Yoshirou Matsumoto
Publication date
01-06-2003
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 6/2003
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-002-1099-y

Other articles of this Issue 6/2003

Journal of Gastroenterology 6/2003 Go to the issue

Case report

Follicular lymphoma of the stomach: immunohistochemical and molecular genetic studies

Letter to the editor

Eosinophilic colitis accompanied by Tolosa–Hunt syndrome: report of a case

OriginalPaper

Bezafibrate treatment: a new medical approach for PBC patients?

Case report

Hepatobiliary cystadenoma with mesenchymal stroma in a patient with chronic hepatitis C

Case report

A patient with hepatitis C-related liver cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy

Letter to the editor

Primary coexistent neuroendocrine carcinoma, hepatoid adenocarcinoma, and tubular adenocarcinoma of the stomach with focal trophoblastic differentiation in metastatic lymph nodes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits